An Approach to Lipid Testing
 |
Mary E. Tang, M.D. May 1998 |
|
Lipid Testing Evaluation and Treatment Recommendations
The approach to lipid testing involves review of the risk factors, a list of appropriate tests to be performed, and evaluation, treatment and follow up. The approach outlined below is based on the summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). Reference: JAMA, June 16, 1993 - Vol 269, No. 23.
Dr. Mary Tang is a Clinical Pathologist at Fletcher Allen Health Care in Burlington, Vermont. Questions regarding this protocol may be directed to Dr. Tang at 802-847-5121 or 800-991-2799.
Lipid Testing
Risk Factors:
|
Male>/=45 years |
_____________ |
|
Female>/=55 years(or premature menopause w/o Estrogen Tx |
_____________ |
|
Family history of coronary artery disease in a male<55 or female<65 |
_____________ |
|
Smoker |
_____________ |
|
Hypertension |
_____________ |
|
Diabetes |
_____________ |
|
HDL<35mg/dL. |
_____________ |
|
HDL>/=60 - subtract one risk factor |
_____________ |
| |
|
|
Total # of risk factors |
_____________ |
Tests: Cholesterol & HDL, on all patients over 18 yrs. old (does not need to be fasting)
|
Cholesterol |
___________ |
|
HDL |
___________ |
Patients with known Coronary Heart Disease require a lipid profile (fasting sample required)
Back to Top
Evaluation, Treatment & Follow Up Lipid Testing
All patients: General dietary, risk factor and physical activity recommendations.
|
Cholesterol mg/dl |
HDL mg/dl |
Risk Factors |
Follow up |
|
<200 |
>/=35 |
|
Recheck Cholesterol & HDL within 5 years |
|
200-239 |
>/=35 |
0 or 1 |
Recheck Cholesterol & HDL in 1-2 years |
|
200-239 |
>/=35 |
2 or more |
Do Lipid profile |
|
>/=240 |
|
|
Do Lipid profile |
| |
<35 |
|
Do Lipid profile |
Lipid profile = total cholesterol, HDL cholesterol, triglyceride, calculated LDL cholesterol - Fasting Lipid Profile (Lipid Profile requires fasting sample)
|
LDL* mg/dl |
Risk Factors |
Follow up |
Goal |
|
<130 |
|
Recheck total cholesterol & HDL within 5 years |
|
|
130-159 |
0-1 |
Educate on diet, exercise. Recheck lipid profile yearly |
|
|
130-159 |
2 or more |
Dietary therapy, exercise. Recheck total cholesterol at 4-6 wks. until stable, then at 3, 6, 9, and 12 mo., then every 6 months thereafter |
LDL<130 mg/dl
(Approx. Cholesterol <200 mg/dl) |
|
>/= 160 |
0 or 1 |
Dietary therapy, exercise. Recheck total cholesterol at 4-6 wks. until stable, then at 3, 6, 9, and 12 mo., then every 6 months thereafter |
LDL<160 mg/dl
(Approx. Cholesterol <240mg/dl) |
|
>/= 160 |
2 or more |
Dietary therapy, consider drug therapy. Recheck total cholesterol at 4-6 wks. until stable, then at 3, 6, 9, and 12 mo., then every 4 to 6 months thereafter
Check LDL at least annually |
LDL<160 mg/dl
(Approx. Cholesterol <240mg/dl) |
|
>/= 190 |
0 or 1 |
*based on the average of two LDL determinations
Back to Top
Recommendations for Patients with Known CAD
|
LDL mg/dl |
Follow up |
Goal |
|
<100 |
Recheck Lipid Profile annually |
LDL<100 mg/dl |
|
100-129 |
Dietary therapy, exercise.
Recheck total cholesterol at 4-6 wks. until stable, then at 3,6,9, and 12 mo., then every 6 months thereafter. |
LDL<100 mg/dl |
|
>/= 130 |
Consider drug therapy.
Recheck LDL at 4-6 wks. until stable, then at 3, 6, 9, and 12 mo., then every 4 to 6 months thereafter
Check LDL at least annually |
LDL<100 mg/dl |
This protocol is a joint initiative of NECLA and the VSPS
Back to Top
 |